The Future of Astatine is here
At SNMMI 2026, discover the latest IBA Astatine-211 dedicated technologies —where precision, reliability, and performance come together for alpha-based targeted cancer therapies.
Be there to celebrate together the Future of Targeted Alpha Therapy, a special moment to connect and celebrate around light refreshments.
Seats are limited → book your seat now
- Sunday, May 31 – 3.30 PM
- IBA booth #2023
Book your seat now
Be the first to discover it and get the experts perspective